Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hikma Pharmaceuticals Plc stock logo
HKMPF
Hikma Pharmaceuticals
$27.73
$27.37
$22.56
$28.92
$6.15B0.57101 shsN/A
Hitachi Constr stock logo
HTCMY
Hitachi Constr
$57.00
-5.0%
$59.24
$40.85
$60.02
$6.06B0.3752 shs600 shs
Jfe Holdings Inc. stock logo
JFEEF
JFE
$11.40
$12.51
$10.40
$13.30
$7.25B0.4531 shsN/A
Monotaro stock logo
MONOY
Monotaro
$19.37
-2.2%
$20.05
$11.08
$21.63
N/A0.7932,150 shs36,927 shs
Orion OYJ Unsponsored ADR stock logo
ORINY
Orion OYJ
$37.18
$34.04
$21.10
$37.53
$10.49B0.1112 shs8 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hikma Pharmaceuticals Plc stock logo
HKMPF
Hikma Pharmaceuticals
0.00%0.00%0.00%+5.86%+9.82%
Hitachi Constr stock logo
HTCMY
Hitachi Constr
0.00%-3.89%-3.89%+7.70%+5.93%
Jfe Holdings Inc. stock logo
JFEEF
JFE
0.00%0.00%-12.71%-14.29%-20.06%
Monotaro stock logo
MONOY
Monotaro
0.00%-2.87%-5.09%+7.54%+69.50%
Orion OYJ Unsponsored ADR stock logo
ORINY
Orion OYJ
0.00%0.00%+5.87%+19.55%+74.51%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Hikma Pharmaceuticals Plc stock logo
HKMPF
Hikma Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Hitachi Constr stock logo
HTCMY
Hitachi Constr
N/AN/AN/AN/AN/AN/AN/AN/A
Jfe Holdings Inc. stock logo
JFEEF
JFE
N/AN/AN/AN/AN/AN/AN/AN/A
Monotaro stock logo
MONOY
Monotaro
N/AN/AN/AN/AN/AN/AN/AN/A
Orion OYJ Unsponsored ADR stock logo
ORINY
Orion OYJ
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hikma Pharmaceuticals Plc stock logo
HKMPF
Hikma Pharmaceuticals
3.50
Strong BuyN/AN/A
Hitachi Constr stock logo
HTCMY
Hitachi Constr
0.00
N/AN/AN/A
Jfe Holdings Inc. stock logo
JFEEF
JFE
0.00
N/AN/AN/A
Monotaro stock logo
MONOY
Monotaro
2.00
HoldN/AN/A
Orion OYJ Unsponsored ADR stock logo
ORINY
Orion OYJ
2.00
HoldN/AN/A

Current Analyst Ratings Breakdown

Latest HTCMY, MONOY, JFEEF, ORINY, and HKMPF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/13/2025
Monotaro stock logo
MONOY
Monotaro
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Hold
5/13/2025
Hikma Pharmaceuticals Plc stock logo
HKMPF
Hikma Pharmaceuticals
BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform
(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hikma Pharmaceuticals Plc stock logo
HKMPF
Hikma Pharmaceuticals
$3.13B1.97$2.23 per share12.43$10.46 per share2.65
Hitachi Constr stock logo
HTCMY
Hitachi Constr
$9.01B0.67$9.52 per share5.99$53.24 per share1.07
Jfe Holdings Inc. stock logo
JFEEF
JFE
$31.91B0.23$3.62 per share3.15$26.85 per share0.42
Monotaro stock logo
MONOY
Monotaro
$1.91BN/A$0.43 per share45.56$1.37 per shareN/A
Orion OYJ Unsponsored ADR stock logo
ORINY
Orion OYJ
$1.67B6.29$1.62 per share22.94$3.85 per share9.66
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hikma Pharmaceuticals Plc stock logo
HKMPF
Hikma Pharmaceuticals
$359MN/A0.00N/AN/AN/AN/A8/7/2025 (Estimated)
Hitachi Constr stock logo
HTCMY
Hitachi Constr
$537.42M$5.4510.4610.61N/AN/AN/AN/A7/25/2025 (Estimated)
Jfe Holdings Inc. stock logo
JFEEF
JFE
$606.33M$0.9112.53N/A1.88%3.56%1.61%8/4/2025 (Estimated)
Monotaro stock logo
MONOY
Monotaro
$173.82M$0.4543.0542.12N/A9.19%33.01%23.95%7/30/2025 (Estimated)
Orion OYJ Unsponsored ADR stock logo
ORINY
Orion OYJ
$356.98M$1.3128.3828.60N/A21.74%36.23%21.28%7/18/2025 (Estimated)

Latest HTCMY, MONOY, JFEEF, ORINY, and HKMPF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q4 2025
Jfe Holdings Inc. stock logo
JFEEF
JFE
-$0.0572-$0.08-$0.0229-$0.08$7.99 billion$7.89 billion
5/1/2025Q1 2025
Monotaro stock logo
MONOY
Monotaro
N/A$0.10N/A$0.10$554.00 million$518.86 million
4/23/2025Q1 2025
Orion OYJ Unsponsored ADR stock logo
ORINY
Orion OYJ
N/A$0.23N/A$0.23N/A$373.03 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Hikma Pharmaceuticals Plc stock logo
HKMPF
Hikma Pharmaceuticals
$0.963.46%N/AN/AN/A
Hitachi Constr stock logo
HTCMY
Hitachi Constr
$2.294.02%N/A42.02%N/A
Jfe Holdings Inc. stock logo
JFEEF
JFE
N/AN/AN/AN/AN/A
Monotaro stock logo
MONOY
Monotaro
$0.080.41%N/A17.78%N/A
Orion OYJ Unsponsored ADR stock logo
ORINY
Orion OYJ
$0.320.86%N/A24.43%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hikma Pharmaceuticals Plc stock logo
HKMPF
Hikma Pharmaceuticals
0.28
1.14
0.65
Hitachi Constr stock logo
HTCMY
Hitachi Constr
0.25
1.63
0.77
Jfe Holdings Inc. stock logo
JFEEF
JFE
0.53
1.61
0.77
Monotaro stock logo
MONOY
Monotaro
0.01
2.68
2.08
Orion OYJ Unsponsored ADR stock logo
ORINY
Orion OYJ
0.27
3.79
2.27

Institutional Ownership

CompanyInstitutional Ownership
Hikma Pharmaceuticals Plc stock logo
HKMPF
Hikma Pharmaceuticals
N/A
Hitachi Constr stock logo
HTCMY
Hitachi Constr
N/A
Jfe Holdings Inc. stock logo
JFEEF
JFE
N/A
Monotaro stock logo
MONOY
Monotaro
0.06%
Orion OYJ Unsponsored ADR stock logo
ORINY
Orion OYJ
N/A

Insider Ownership

CompanyInsider Ownership
Hikma Pharmaceuticals Plc stock logo
HKMPF
Hikma Pharmaceuticals
N/A
Hitachi Constr stock logo
HTCMY
Hitachi Constr
N/A
Jfe Holdings Inc. stock logo
JFEEF
JFE
N/A
Monotaro stock logo
MONOY
Monotaro
N/A
Orion OYJ Unsponsored ADR stock logo
ORINY
Orion OYJ
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Hikma Pharmaceuticals Plc stock logo
HKMPF
Hikma Pharmaceuticals
9,500221.89 millionN/ANot Optionable
Hitachi Constr stock logo
HTCMY
Hitachi Constr
26,230106.35 millionN/ANot Optionable
Jfe Holdings Inc. stock logo
JFEEF
JFE
62,218635.96 millionN/ANot Optionable
Monotaro stock logo
MONOY
Monotaro
1,375N/AN/ANot Optionable
Orion OYJ Unsponsored ADR stock logo
ORINY
Orion OYJ
3,712282.27 millionN/ANot Optionable

Recent News About These Companies

Critical Analysis: Orion OYJ (ORINY) and Its Competitors
Orion Oyj (OTCMKTS:ORINY) Short Interest Update
European Dividend Stocks To Consider In April 2025
Orion Group Interim Report January–March 2025
Q4 2024 Orion Oyj Earnings Call Transcript
3 Reliable Dividend Stocks Offering Yields Up To 4.5%
Orion Oyj ADR
3 Prominent Dividend Stocks For November 2024

Media Sentiment Over Time

Hikma Pharmaceuticals stock logo

Hikma Pharmaceuticals OTCMKTS:HKMPF

$27.73 0.00 (0.00%)
As of 07/3/2025

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Hitachi Constr stock logo

Hitachi Constr OTCMKTS:HTCMY

$57.00 -3.02 (-5.03%)
As of 07/3/2025 09:30 AM Eastern

Hitachi Construction Machinery Co., Ltd., together with its subsidiaries, manufactures and sells construction machineries worldwide. The company operates through two segments, Construction Machinery Business and Solution Business. It offers excavators and wheel loaders, hydraulic excavators, compaction equipment, and rigid dump trucks. The company also provides ICT construction solutions; ConSite that monitors machines' operational status and alarms by sending monthly operational reports, as well as notifies emergency alarms; Fleet management system, which offers real-time monitoring of dump truck for optimizing vehicle operations; and autonomous haulage system for autonomous operation of mining dump trucks. In addition, it provides parts and services; used equipment under the PREMIUM USED brand; machinery rental services under the PREMIUM RENTAL and REC brand names; and parts remanufacturing services. The company was incorporated in 1951 and is headquartered in Taito, Japan. Hitachi Construction Machinery Co., Ltd. is a subsidiary of Hitachi, Ltd.

JFE stock logo

JFE OTCMKTS:JFEEF

$11.40 0.00 (0.00%)
As of 07/3/2025

JFE Holdings, Inc., through its subsidiaries, engages in steel, engineering, and trading businesses in Japan and internationally. Its Steel segment produces and sells various steel products, processed steel products, and raw materials, as well as operates in the transportation, facility maintenance, and construction businesses. The company's Engineering segment handles the engineering of energy, urban environment, steel structures and industrial machinery, recycling, and electricity retailing projects. Its Trading segment purchases, processes, and distributes steel products, raw materials for steel production, nonferrous metal products, food, etc. JFE Holdings, Inc. was incorporated in 2002 and is headquartered in Tokyo, Japan.

Monotaro stock logo

Monotaro OTCMKTS:MONOY

$19.37 -0.43 (-2.15%)
As of 07/3/2025 12:59 PM Eastern

MonotaRO Co., Ltd., together with its subsidiaries, operates an online MRO products store in Japan and internationally. The company offers safety protective equipment, work clothes, and safety shoes; logistics, storage, and packing supplies; tapes; safety, disaster prevention, and crime prevention products; safety signs; ship and fishing supplies; office supplies; office furniture/lighting/cleaning supplies; cutting tools and abrasives; measurement and surveying equipment; hand tools/electric and pneumatic tools; sprays, oils, greases, and paints; adhesives and repair materials; welding supplies; and piping and water related components/pumps/pneumatic and hydraulic equipment/hoses. It also provides mechanical parts; control equipment; soldering and anti-static products; architectural hardware, building materials, painting, and interior supplies; air conditioning and electrical equipment; electrical materials; screws, bolts, nails, and materials; automotive supplies; truck supplies; motorcycle supplies; bicycle supplies; scientific research and development supplies; clean room supplies; kitchen equipment and store supplies; agricultural and gardening supplies; and medical and nursing supplies. It serves factories, construction, automobile maintenance, and other industries. The company was formerly known as Sumisho Grainger Co., Ltd. and changed its name to MonotaRO Co., Ltd. in February 2006. The company was incorporated in 2000 and is headquartered in Osaka, Japan. MonotaRO Co., Ltd. operates as a subsidiary of Grainger Global Holdings, Inc.

Orion OYJ stock logo

Orion OYJ OTCMKTS:ORINY

$37.18 0.00 (0.00%)
As of 06/30/2025

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. Further, the company has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.